Epidermodysplasia verruciformis occurring in a patient with human immunodeficiency virus: A case report

GOAL To understand epidermodysplasia verruciformis (EV) to better manage patients with the condition OBJECTIVES Upon completion of this activity, dermatologists and general practitioners should be able to: 1. Describe the 2 forms of EV. 2. Discuss the link between immunodeficiency and EV. 3. Identify therapies for EV. CME Test on page 306. This article has been peer reviewed and approved Einstein College of Medicine is accredited by by Michael Fisher, MD, Professor of Medicine Albert Einstein College of Medicine, Review date March 2007. This activity has been planned and implemented in accordance with the Essential areas and policies of the Accreditation Council for continuing Medical Education through the joint sponsorship of Albert Einstein College of Medicine and Quadrant HealthCom Inc. Albert Einstein College of Medicine is accredited by the ACCME to providing continuing medical education for physicians. Albert Einstein College of Medicine designates this educational activity for a maximum of 1 AMA PRA Catedgory 1 Credit (TM). Physicians should only claim credit commensurate with the participation in the activity. This activity has been planned and produced in accordance with ACCME Essentials.